Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Dec 7, 2022 | Apogee Therapeutics | Series B | — | Biotechnology | Yes |
Jul 18, 2022 | Immunocore | Post-IPO Equity | — | Biotechnology | — |
Oct 7, 2021 | Science 37 | Post-IPO Equity | — | Biotechnology | — |
Oct 1, 2021 | Roivant Sciences | Post-IPO Equity | — | Biopharma | — |
Aug 30, 2021 | Rocket Pharmaceuticals | Post-IPO Equity | — | Biotechnology | Yes |
May 5, 2021 | NeoGenomics | Post-IPO Equity | — | Biotechnology | — |
Mar 1, 2021 | Tenaya Therapeutics | Series C | — | Biopharma | Yes |
Nov 9, 2020 | Prometheus Biosciences | Private Equity(PE) | — | Biotechnology | Yes |
Mar 2, 2020 | Immunocore | Series B | — | Biotechnology | — |
Nov 13, 2019 | Avidity Biosciences | Series C | — | Biotechnology | Yes |
Nov 13, 2018 | Roivant Sciences | Private Equity(PE) | — | Biopharma | Yes |
Jul 16, 2015 | Immunocore | Series A | — | Biotechnology | — |